Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11897-014-0226-4 http://scihub22266oqcxt.onion/10.1007/s11897-014-0226-4 C4224613!4224613!25239434     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Heart+Fail+Rep 2014 ; 11 (4): 485-99 Nephropedia Template TP {{tp|p=25239434|t=2014. Novel Renal Biomarkers to Assess Cardiorenal Syndrome |pdf=|usr=}}{{25239434}} gab.com Text Novel Renal Biomarkers to Assess Cardiorenal Syndrome JO: Curr Heart Fail Rep http://www.kidney.de/pget.php?&tw=1&pmid=25239434 #FOAvip Renal dysfunction (RD) in heart failure portends adverse outcomes and often limits aggressive medical and decongestive therapies. Despite the high prevalence in this population, not all forms of RD are prognostically or mechanistically equivalent: RD can result from irreversible nephron loss secondary to diabetic or hypertensive kidney disease or it can develop secondary to the HF itself, i.e. the cardiorenal syndrome. Furthermore, filtration is only one aspect of renal performance such that significant renal impairment secondary to cardiorenal syndrome can exist despite a normal glomerular filtration rate. Renal biomarkers have the potential to inform some of the intricacies involved in accurately assessing cardiorenal interactions. This article discusses novel biomarkers for cardiorenal syndrome and their utility in prognosis, diagnosis, and targeted treatment of heart failure-induced RD. Twit Text FOAVip Novel Renal Biomarkers to Assess Cardiorenal Syndrome ????Curr Heart Fail Rep http://www.kidney.de/pget.php?&tw=1&pmid=25239434 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25239434 #FOAvip English Wikipedia <ref>{{Cite pmid|25239434}}</ref> Novel Renal Biomarkers to Assess Cardiorenal Syndrome #MMPMID25239434 Brisco MA; Testani JM Curr Heart Fail Rep 2014[Dec]; 11 (4): 485-99 PMID25239434show ga Renal dysfunction (RD) in heart failure portends adverse outcomes and often limits aggressive medical and decongestive therapies. Despite the high prevalence in this population, not all forms of RD are prognostically or mechanistically equivalent: RD can result from irreversible nephron loss secondary to diabetic or hypertensive kidney disease or it can develop secondary to the HF itself, i.e. the cardiorenal syndrome. Furthermore, filtration is only one aspect of renal performance such that significant renal impairment secondary to cardiorenal syndrome can exist despite a normal glomerular filtration rate. Renal biomarkers have the potential to inform some of the intricacies involved in accurately assessing cardiorenal interactions. This article discusses novel biomarkers for cardiorenal syndrome and their utility in prognosis, diagnosis, and targeted treatment of heart failure-induced RD. äNovel Renal Biomarkers to Assess Cardiorenal Syndrome (epmc).pdf DeepDyve Pubget Overpricing